WCN24-1808 TREATMENT OF SECONDARY HYPERPARATHYROIDISM WITH ETELCALCETIDE IN ARGENTINA
Saved in:
| Main Authors: | Daniela Wojtowicz, Gustavo Laham, Cecilia Mengarelli, Armando Negri, Rita Canale, Elisa Del Valle, Graciela Filannino, Adriana Peñalba, Guillermo Rosa Diez, Sammartino Andrea, Mariano Forrester |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-04-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924009318 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Application of the calcimimetic agent Etelcalcetide in the treatment of secondary hyperparathyroidism in hemodialysis patients
by: DENG Hua, et al.
Published: (2019-01-01) -
Real-world safety profile of etelcalcetide in dialysis-related secondary hyperparathyroidism: a pharmacovigilance analysis of FAERS data
by: Cong Zou, et al.
Published: (2025-12-01) -
An Initial Low-Dose Etelcalcetide Dosing Strategy in Hemodialysis Patients With Moderate Secondary Hyperparathyroidism is Effective and Cost-Saving
by: Andrea Carta, et al.
Published: (2024-02-01) -
WCN25-1200 A CLINICAL AUDIT COMPARING LOW AND STANDARD DOSES OF INTRAVENOUS ETELCALCETIDE IN HAEMODIALYSIS PATIENTS
by: XiaoJie Qu, et al.
Published: (2025-02-01) -
Etelcalcetide: What we know eight years since its approval
by: Pedro Freitas, et al.
Published: (2025-02-01)